HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chromosome studies in preleukemic states. V. Prognostic significance of single versus multiple abnormalities.

Abstract
The prognostic value of marrow chromosome findings was examined in 242 patients with preleukemic myelodysplastic syndromes (MDS) or myeloproliferative disorders (MPD), with emphasis on the significance of single versus multiple karyotypic changes. In both groups, the results showed that patients with multiple chromosome abnormalities in a marrow clone had a very high probability of early death, from progression to leukemia or from other complications of hematopoietic dysfunction. Conversely, in patients with a hemic clone having only one karyotypic alteration (involving a single chromosome or single translocation), survival over 2 years was only slightly reduced as compared to those without chromosome abnormality. The only single karyotypic alteration perhaps associated with a markedly shortened survival was monosomy 7. These findings suggest that the conclusions of previous studies concerning the grave consequences of chromosome alterations in preleukemia largely reflect the clinical significance of clones with multiple cytogenetic changes. Prior knowledge of the karyotypic status of preleukemic patients should be helpful in evaluating current attempts to find effective treatment for these difficult disorders.
AuthorsP C Nowell, E C Besa, T Stelmach, J B Finan
JournalCancer (Cancer) Vol. 58 Issue 12 Pg. 2571-5 (Dec 15 1986) ISSN: 0008-543X [Print] United States
PMID3779606 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Aged
  • Bone Marrow (ultrastructure)
  • Chromosome Aberrations
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myeloproliferative Disorders (genetics)
  • Preleukemia (genetics)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: